The overall biotech market is looking up, but in the ever-changing healthcare landscape, some areas are always hotter than others. At the height of the pandemic, for example, digital health and telehealth became booming industries. But now there are new players in town, reports Cure's Ready, Set, Growth! Biotech Benchmark Report 2024 survey. 

Pharma molecules biotech

The New Players in Town

Andrew S. Plump, MD, PhD, President of Research & Development at Takeda Pharmaceutical Company Limited, discusses  changes needed in the way we approach science to achieve cures.

What Will It Take to Deliver Cures to Society?

Blue

The FDA is setting new priorities designed to bring innovative healthcare products to market faster, though concerns about political interference at federal science agencies complicate the picture.

FDA Shares New Priorities and ‘Proactive’ Approach to Working with Developers

Sunbird Bio's platform aims to address a $20 billion global neurology diagnostics market to test for Alzheimer’s, Parkinson’s, ALS and more. 

How Sunbird Bio is Changing Brain Disease Diagnoses  

First Patients Join Study of Wandercraft Home-Use Exoskeleton

The FDA recently announced a new Rare Disease Innovation Hub, designed to expedite development and approval of new treatments for patients with rare diseases. Cure Xchange Challenge winner Every Cure weighs in.

Every Cure’s Grant Mitchell on Hopes and Challenges for the FDA’s New Rare Disease Hub

Understanding how life sciences entrepreneurs can best use patents and copyrights to safeguard IP as an asset offers protection against others copying the discovery and can help set up a smoother path to market.
 

thumbnail-intellectual-property-article

The Ins and Outs of Intellectual Property in Life Sciences

Matthew Feeley, JD, MA, a DOJ Deputy Chief and Healthcare Fraud Coordinator, recommends five steps healthcare entrepreneurs can use to help protect their companies.

thumbnail_tuesday_talks_matthew_feeley

Keeping It Legal: Five Tips for Entrepreneurs from Department of Justice Attorney

Finding the right participants is often an expensive bottleneck for clinical trials.

Five Challenges to Clinical Trials Access and Recruitment

What 5 things will it take for science to move toward more inclusivity and collaboration? At the United Nations Science Summit, Cure's panel yielded five takeaways.

The Future of Science and Inclusivity: 5 Things That Need to Happen

Clinical trials leave pregnant women on the sidelines. Infectious disease physician and leading vaccine developer Judith Absalon, MD, MPH, FIDSA, offers insight into issues around women in science.

MVP-INSIGHTS_ARTICLE-Increasing Women in Science

Increasing Women in Science—as Clinical Research Leaders and Participants

Insights

Events

Become a member of Cure and help shape the future of healthcare.

Join our community

Regular

345 Park Avenue South

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

AI-Powered Companies Dominate 2025 Digital Health Funding

Cure’s Landmark Report Reveals 87% of Healthcare Leaders Remain Optimistic About Future, Despite Challenges

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Regulatory and Clinical Strategy

Insights

Recommended Topics

Join our community